Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
02 2021
Historique:
entrez: 5 2 2021
pubmed: 6 2 2021
medline: 10 2 2021
Statut: ppublish

Résumé

Two London care homes experienced a second COVID-19 outbreak, with 29/209 (13.9%) SARS-CoV-2 RT-PCR-positive cases (16/103 residents, 13/106 staff). In those with prior SARS-CoV-2 exposure, 1/88 (1.1%) individuals (antibody positive: 87; RT-PCR-positive: 1) became PCR-positive compared with 22/73 (30.1%) with confirmed seronegative status. After four months protection offered by prior infection against re-infection was 96.2% (95% confidence interval (CI): 72.7-99.5%) using risk ratios from comparison of proportions and 96.1% (95% CI: 78.8-99.3%) using a penalised logistic regression model.

Identifiants

pubmed: 33541486
doi: 10.2807/1560-7917.ES.2021.26.5.2100092
pmc: PMC7863231
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Infect. 2020 Sep 16;:4840
pubmed: 32949618
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Euro Surveill. 2020 Jul;25(28):
pubmed: 32700670
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
J Infect. 2020 Aug 27;:
pubmed: 32860817
EClinicalMedicine. 2020 Nov;28:100597
pubmed: 33173854
EClinicalMedicine. 2020 Sep;26:100533
pubmed: 32923993
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
Lancet Microbe. 2020 Nov;1(7):e283-e289
pubmed: 33015652
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32826322
Clin Infect Dis. 2020 Dec 31;71(11):2920-2926
pubmed: 32548628

Auteurs

Anna Jeffery-Smith (A)

National Infection Service Public Health England, London, United Kingdom.

Nalini Iyanger (N)

London Coronavirus Response Centre, Public Health England, London, United Kingdom.

Sarah V Williams (SV)

London Coronavirus Response Centre, Public Health England, London, United Kingdom.

J Yimmy Chow (JY)

London Coronavirus Response Centre, Public Health England, London, United Kingdom.

Felicity Aiano (F)

National Infection Service Public Health England, London, United Kingdom.

Katja Hoschler (K)

National Infection Service Public Health England, London, United Kingdom.

Angie Lackenby (A)

National Infection Service Public Health England, London, United Kingdom.

Joanna Ellis (J)

National Infection Service Public Health England, London, United Kingdom.

Steven Platt (S)

National Infection Service Public Health England, London, United Kingdom.

Shahjahan Miah (S)

National Infection Service Public Health England, London, United Kingdom.

Kevin Brown (K)

National Infection Service Public Health England, London, United Kingdom.

Gayatri Amirthalingam (G)

National Infection Service Public Health England, London, United Kingdom.

Monika Patel (M)

National Infection Service Public Health England, London, United Kingdom.

Mary E Ramsay (ME)

National Infection Service Public Health England, London, United Kingdom.

Robin Gopal (R)

National Infection Service Public Health England, London, United Kingdom.

Andre Charlett (A)

Data and Analytical Sciences, Public Health England, London, United Kingdom.

Shamez N Ladhani (SN)

National Infection Service Public Health England, London, United Kingdom.

Maria Zambon (M)

National Infection Service Public Health England, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH